2025 Global Antimicrobial Susceptibility Testing Market Revenue Opportunities Report
Description
The 2025 Global Antimicrobial Susceptibility Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global Antimicrobial Susceptibility Testing (AST) market are bioMérieux, Becton Dickinson (BD), Thermo Fisher Scientific, and Danaher Corporation. bioMérieux offers the VITEK® series and innovative microbiology software MAESTRIA to deliver rapid, reliable susceptibility testing globally. BD is a key player providing automated diagnostic solutions widely used in healthcare settings to combat antimicrobial resistance. Thermo Fisher Scientific delivers advanced diagnostic platforms such as the Sensititre and MAS systems, critical for precise susceptibility profiling. Danaher, through its subsidiary Cepheid, launched rapid molecular tests for multi-drug resistant tuberculosis, demonstrating innovation in quick resistance detection.
These companies drive market growth by continuously investing in R&D to develop automated, accurate, and rapid antimicrobial susceptibility testing technologies. Their global presence enables them to address the rising threat of antibiotic-resistant infections worldwide, supporting hospitals, diagnostic laboratories, and pharmaceutical research. The increasing prevalence of resistant bacterial strains and government support to combat antimicrobial resistance further accelerate their competitive advancements and market expansion. Collaborations with pharmaceutical companies and innovations in molecular and genomic techniques emphasize their strategic roles in advancing antimicrobial susceptibility diagnostics on a global scale.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the global Antimicrobial Susceptibility Testing (AST) market are bioMérieux, Becton Dickinson (BD), Thermo Fisher Scientific, and Danaher Corporation. bioMérieux offers the VITEK® series and innovative microbiology software MAESTRIA to deliver rapid, reliable susceptibility testing globally. BD is a key player providing automated diagnostic solutions widely used in healthcare settings to combat antimicrobial resistance. Thermo Fisher Scientific delivers advanced diagnostic platforms such as the Sensititre and MAS systems, critical for precise susceptibility profiling. Danaher, through its subsidiary Cepheid, launched rapid molecular tests for multi-drug resistant tuberculosis, demonstrating innovation in quick resistance detection.
These companies drive market growth by continuously investing in R&D to develop automated, accurate, and rapid antimicrobial susceptibility testing technologies. Their global presence enables them to address the rising threat of antibiotic-resistant infections worldwide, supporting hospitals, diagnostic laboratories, and pharmaceutical research. The increasing prevalence of resistant bacterial strains and government support to combat antimicrobial resistance further accelerate their competitive advancements and market expansion. Collaborations with pharmaceutical companies and innovations in molecular and genomic techniques emphasize their strategic roles in advancing antimicrobial susceptibility diagnostics on a global scale.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
